Anika Gains Australia Approval for MONOVISC Viscosupplement

Anika Therapeutics (ANIK) received Australia regulatory approval to market MONOVISC® single-injection viscosupplement for the treatment of osteoarthritis pain in all synovial joints. MONOVISC is now available in 20+ counties, including the 3Q17 addition of India, and ANIK plans to add more in 2018.

Surgical Specialties will market MONOVISC...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us